New dimension for efficient laboratory work
Laboratory SaaS provider Labforward ramps up Series B financing to >€8.5 million in second closing
With the successful completion of a second closing, Labforward adds >€3m to the Series B from January, bringing the total funds raised to >€8.5m. The majority of the new investment comes from the Fielmann Family Office, majority owner of the leading German family business of the same name that serves its 27m customers across 15 European markets with eyewear and hearing aids.
Labforward
Labforward has completed a second closing for its Series B. The family office of the Fielmann family, the existing investor IBB Ventures as well as existing and new business angels invest in the laboratory software company with headquarters in Berlin, Germany.
Laboratories have always involved a lot of manual processes that require the presence of an entire laboratory team on site. In the COVID 19 crisis, the degree to which labs have already digitized or automated these processes makes the difference between being able to safely continue important scientific work or having to choose between a complete shutdown or putting employees at risk for several months.
“Last year's experience showed lab teams the importance of investing in automation and digital data management to keep a lab running with fewer on-site staff.” as Dr. Simon Bungers, co-founder and CEO of the company explains: “We’re seeing increased demand for our solutions which let teams control devices remotely, capture data digitally and let scientists access the data in the cloud or an accessible server for analysis and process optimization.”
Innovative digital solutions that improve processes of life science companies, the pharma industry and healthcare in general are at the core of the investment focus of the team behind the Fielmann Family Office. “We are actively searching for software solutions that increase productivity and efficiency in the healthcare industry.” as Peter Stauffer, managing director of the family office explains. He continues: “After experiencing the COVID crisis, no one will accept average drug development cycles of 12 years anymore. Labforward´s manufacturer-independent and device-agnostic offering allows a new dimension for efficient laboratory work and supports the shortening of drug development cycles. We are happy to
invest in the company's growth and to enable the digitization of laboratories around the globe.”
With the additional funding, Labforward is going to invest in further expansion of the team and making the fully-digitized laboratory of the future more accessible to organizations that look for smart solutions for their laboratories. “Together with partners from the industry, we are currently building a showroom laboratory in Berlin. There, laboratory teams from around the world can experience what is possible with the technology of today. It’s going to be a great place to demonstrate how connected laboratories work and it also allows us to test a lot of ideas and innovations.” Simon Bungers explains.
The showroom is going to be opened in summer of this year.
Other news from the department business & finance
These products might interest you
Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management
Laboperator, Labfolder & Labregister by labforward
Laboratory of the future: applications for a laboratory operating system
Labforward is creating the operating system of the lab by connecting data, teams & devices
VisioNize® Lab Suite by Eppendorf
VisioNize Lab Suite - cloud-based lab and device management platform
Designed to empower you to focus on your next breakthrough
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.
